ACP Diabetes Monthly
Welcome to this month's issue of ACP Diabetes Monthly, an update for internists published by the American College of Physicians.
In the News for the month of April 2016
SGLT2 inhibitors may protect against some major cardiovascular events
Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with lower risk of major adverse cardiovascular events and death from any cause, but there was no clear effect on nonfatal myocardial infarction and researchers noted an adverse effect for nonfatal stroke. More...
Pioglitazone, but not rosiglitazone, associated with increased risk of bladder cancer
The results of this study pose the question of whether the increased likelihood of bladder cancer, which is rare, justifies withholding pioglitazone from adults with type 2 diabetes, according to an accompanying editorial. More...
Incretin-based drugs not associated with greater heart failure hospitalization risk than other drug combos in retrospective study
Researchers compared patients taking dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues to those taking 2 or more oral antidiabetic drugs. More...
MKSAP quiz: History of diabetic ketoacidosis
This month's case asks readers to evaluate a 44-year-old man diagnosed with type 2 diabetes 6 months ago after being admitted to the hospital with diabetic ketoacidosis. More...
New warnings on medications containing saxagliptin, alogliptin
New warnings will be placed on saxagliptin and alogliptin about the potential risk of heart failure, particularly in patients with heart or kidney disease, the FDA announced on April 5. More...
Safety alert and advice on CT scanning in patients with insulin pumps
The presence of an insulin pump should not preclude an appropriate and medically indicated CT scan, the FDA said. More...
Spotlight on drug comparisons
Outcomes and costs of different classes of diabetes drugs were compared by studies published in the past month. More...
Physician editor: David V. O'Dell, MD, FACP
Has Your Contact Information Changed?
To change your e-mail address or other contact information in our records, go here or call 800-523-1546, ext. 2600 (M-F, 9 a.m. - 5 p.m. ET).
About ACP Diabetes Monthly
ACP Diabetes Monthly is a monthly newsletter produced by the staff of ACP Internist. It is automatically sent to all College members who have an e-mail address on file with ACP.
To add your e-mail address to your member record and to begin receiving ACP Diabetes Monthly, please click here.
Copyright © by American College of Physicians.
A 68-year-old woman undergoes upper endoscopy for evaluation of dyspepsia. She has a history of pernicious anemia. She has no other medical problems and her only medication is oral vitamin B12. Upper endoscopy discloses a 6-mm polyp in the body of the stomach, which is removed by polypectomy. Pathologic examination of the polyp confirms a well-differentiated neuroendocrine tumor. What is the most appropriate management?
Not an ACP Member?
Join today and discover the benefits waiting for you.
ACP offers different categories of membership depending on your career stage and professional status. View options, pricing and benefits.
A New Way to Ace the Boards!
Ensure you're board-exam ready with ACP's Board Prep Ace - a multifaceted, self-study program that prepares you to pass the ABIM Certification Exam in internal medicine. Learn more.